Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant

Stopped early · Not applicable

Conditions studied: Malignant Neoplasm

In brief

This clinical trial studies the use of early oral supplementation in improving nutritional status in participants undergoing hematopoietic stem cell transplant. Impaired nutritional status in participants undergoing hematopoietic stem cell transplant has been linked to decreased outcomes such as increased length of hospital stay and increased time to engraftment (an important milestone in transplant recovery). Early oral supplementation may increase nutritional status and help to promote a positive outcome in participants undergoing transplant.

Key facts

Study ID

NCT02590107

Run by

Case Comprehensive Cancer Center

People needed

5

Starts

2016-04-01

Expected to finish

2018-03-01

Last updated by the study team

2018-05-15

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Undergoing an autologous or reduced intensity conditioning (RIC) allogeneic HSCT
• A serum albumin greater than or equal to 2.5 g/dL
• Able to understand and sign consent

You may not qualify if…

• Patients who have malabsorption problems, such as ulcerative colitis, irritable bowel syndrome, Crohn's disease, bowel surgery such as gastric bypass, and celiac disease

Where it is running

• Case Comprehensive Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.